Obesity, defined as a body mass index (BMI) of 30 or more, is a global health issue that poses significant challenges to healthcare professionals. It is associated with numerous comorbidities, including cardiovascular disease, type 2 diabetes, and certain types of cancer. Effective management strategies are crucial to mitigate these risks and improve patient outcomes.
Managing obesity requires a multidisciplinary approach that includes dietitians, psychologists, exercise physiologists, and physicians. Diet and exercise interventions are first-line treatments, but these require significant patient motivation and long-term adherence to be effective. Psychological support can help patients address barriers to lifestyle change and improve adherence.
When lifestyle interventions are insufficient, pharmacological treatments may be considered. Several medications, including orlistat, liraglutide, and bupropion-naltrexone, have been shown to promote weight loss when combined with lifestyle modifications. However, these medications have side effects and contraindications that must be carefully considered.
Bariatric surgery is the most effective treatment for severe obesity (BMI > 40) or moderate obesity (BMI 35-40) with comorbidities. Procedures such as sleeve gastrectomy and gastric bypass can lead to significant and sustained weight loss, but they also carry risks and require lifelong medical follow-up.
Emerging treatments for obesity include novel pharmaceutical agents, endoscopic procedures, and neuromodulation techniques. More research is needed to determine their efficacy and safety. In addition, efforts are underway to better understand the genetic and environmental factors contributing to obesity, which may lead to more personalized treatment strategies.
Obesity management is complex and requires a comprehensive, multidisciplinary approach. Lifestyle interventions remain the cornerstone of treatment, but pharmacological therapies and bariatric surgery play important roles in certain patients. Future research will undoubtedly uncover new strategies for managing this pervasive health issue.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation